Seoul, South Korea

Hyerin Jeong

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyerin Jeong: Innovator in Cognitive Impairment Classification

Introduction

Hyerin Jeong is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cognitive health through his innovative methods for classifying severe cognitive impairment patients. His work is particularly relevant in the context of advancing medical technology and improving patient care.

Latest Patents

Hyerin Jeong holds a patent for a method, server, and computer program designed for classifying severe cognitive impairment patients by analyzing electroencephalogram (EEG) data. This patent outlines a comprehensive approach that includes several classification steps. The process begins with collecting EEG data from multiple users. It then classifies these users into groups based on their cognitive impairment status. The classification includes distinguishing between severe cognitive impairment and non-severe cognitive impairment, as well as further categorizing users into normal, amnestic mild cognitive impairment (aMCI), and preclinical Alzheimer's disease (AD) groups.

Career Highlights

Hyerin Jeong is currently employed at Imedisync, Inc., where he continues to develop and refine his innovative methods. His work is instrumental in enhancing the understanding and treatment of cognitive impairments, which is a growing concern in the medical community.

Collaborations

Hyerin collaborates with talented individuals such as Seung Wan Kang and Ukeob Park. Their combined expertise contributes to the advancement of research and development in the field of cognitive health.

Conclusion

Hyerin Jeong's contributions to the classification of cognitive impairments through EEG data analysis represent a significant advancement in medical technology. His innovative methods have the potential to improve diagnosis and treatment for patients suffering from cognitive impairments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…